DJIA 17,086.63 -26.91 -0.16%
NASDAQ 4,473.70 17.68 0.40%
S&P 500 1,987.01 3.48 0.18%
market minute promo

GlaxoSmithKline (NYSE: GSK)



company name or ticker
Company Photos
(Click to zoom)

GSK faces U.K. fraud investigation

Novartis Settles Litigation Agreement with Acura - Analyst Blog

Novartis Settles Litigation Agreement with Acura - Analyst Blog

4 International Cos. Outdo U.S. Counterparts: Total, Sanofi, More

Data on Novartis' Ultibro Breezhaler - Analyst Blog

The Bull Thesis for Pharmacyclics Into ASCO '14

Glaxo-Genmab's Arzerra Disappoints - Analyst Blog

Glaxo-Genmab's Arzerra Disappoints - Analyst Blog

Healthcare Stocks Ending Mixed; GlaxoSmithKline Slips After Prospective Cancer Drug Fails to Meet Tr

Healthcare Stocks Ending Mixed; GlaxoSmithKline Slips After Prospective Cancer Drug Fails to Meet Trial Endpoints

Sector Update: Healthcare

5 Sector Leader Dogs Sport 9.5% To 42.5% May Gains

Update on Glaxo's Darapladib - Analyst Blog